The results could ultimately help doctors reduce the risk of type 1 diabetes—or potentially even restore pancreas function in adulthood—by providing gut microbes that help the pancreas grow and heal.
Researchers, doctors, and community members came together to improve understanding of the full health, social, and even environmental impacts of these medications.
A combination of human genetic analysis and research in flies identified the protective gene, which could ultimately lead to better therapies for people with the seizure disorder.
There may be up to a tenfold difference in risk for infants who are currently treated identically under clinical guidelines. The analysis is an important step toward more personalized care.
Since 2019, the University of Utah has been developing the world’s most advanced “neuroprosthesis” — an artificial upper arm and hand that is controlled by the user’s thoughts. Named the...
Health sciences research has more than doubled in size over the past 12 years, a trajectory that highlights U of U Health as a destination for leading faculty, learners, and...
The drug lenacapavir, developed by Gilead Sciences, provides protection for half a year instead of one day and has performed extremely well in clinical trials.
The therapy increases the amount of blood the heart can pump and dramatically improves survival, in what a paper describing the results calls “an unprecedented recovery of cardiac function.”
